Sonal Paul

1.2k total citations
16 papers, 36 citations indexed

About

Sonal Paul is a scholar working on Oncology, Genetics and Infectious Diseases. According to data from OpenAlex, Sonal Paul has authored 16 papers receiving a total of 36 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Genetics and 3 papers in Infectious Diseases. Recurrent topics in Sonal Paul's work include COVID-19 Clinical Research Studies (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Neutropenia and Cancer Infections (3 papers). Sonal Paul is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Neutropenia and Cancer Infections (3 papers). Sonal Paul collaborates with scholars based in United States, United Kingdom and Germany. Sonal Paul's co-authors include Uqba Khan, Pallavi Kumar, Vishal Jindal, C. Manegold, K Aigner, Yi‐Hsiang Huang, Christopher E. Desch, Klára Szondy, Dominik Bettinger and Hannah Hildebrand and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Sonal Paul

12 papers receiving 35 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sonal Paul United States	4	16	12	8	7	7	16	36
Alireza Kashefizadeh Iran	4	7 0.4×	12 1.0×	6 0.8×	11 1.6×	4 0.6×	10	32
C. Comarmond France	3	23 1.4×	5 0.4×	5 0.6×	6 0.9×	4 0.6×	8	50
Maryam Bourhaba Belgium	3	10 0.6×	12 1.0×	14 1.8×	4 0.6×	4 0.6×	10	33
Kathryn O’Shea United Kingdom	5	10 0.6×	5 0.4×	11 1.4×	8 1.1×	20 2.9×	12	43
Donghong Cai United States	4	7 0.4×	24 2.0×	9 1.1×	8 1.1×	16 2.3×	14	57
Kensuke Kanaoka Japan	4	23 1.4×	21 1.8×	3 0.4×	7 1.0×	2 0.3×	7	40
Daniela Donnarumma Italy	5	10 0.6×	21 1.8×	7 0.9×	7 1.0×	6 0.9×	7	50
Fatemeh Ziaei United Kingdom	3	22 1.4×	15 1.3×	7 0.9×	6 0.9×	2 0.3×	5	51
Sarah Wishnek Metalonis United States	3	10 0.6×	3 0.3×	6 0.8×	10 1.4×	7 1.0×	5	37
José Presas Argentina	3	17 1.1×	4 0.3×	2 0.3×	6 0.9×	4 0.6×	5	32

Countries citing papers authored by Sonal Paul

Since Specialization

Citations

This map shows the geographic impact of Sonal Paul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonal Paul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonal Paul more than expected).

Fields of papers citing papers by Sonal Paul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonal Paul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonal Paul. The network helps show where Sonal Paul may publish in the future.

Co-authorship network of co-authors of Sonal Paul

This figure shows the co-authorship network connecting the top 25 collaborators of Sonal Paul. A scholar is included among the top collaborators of Sonal Paul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonal Paul. Sonal Paul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Jindal, Vishal, et al.. (2024). Romiplostim for chemotherapy induced thrombocytopenia in solid tumors: A meta-analysis.. Journal of Clinical Oncology. 42(16_suppl). e24137–e24137.

Wolf, Joshua H., et al.. (2024). Adjuvant chemotherapy in stage 1 colon cancer: Patient characteristics and survival analysis from the national cancer database. Surgical Oncology. 54. 102075–102075. 2 indexed citations

Jindal, Vishal, et al.. (2024). Case report: Vitamin B12 deficiency-associated hemolytic anemia. SHILAP Revista de lepidopterología. 3.

Dharmapuri, Sirish, Umut Özbek, Anwaar Saeed, et al.. (2022). Relationship between systemic inflammatory response markers and immune treatment related toxicity (IrAEs) in hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 40(16_suppl). e16204–e16204. 1 indexed citations

Pinato, David J., Ahmed O. Kaseb, Yinghong Wang, et al.. (2020). Impact of baseline and concomitant corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy.. Journal of Clinical Oncology. 38(4_suppl). 531–531. 1 indexed citations

Paul, Sonal, et al.. (2020). Outcomes in COVID-19 Patients on Treatment Dose Anti-Coagulation Compared to Prophylactic Dose Anti-Coagulation. Blood. 136(Supplement 1). 40–41. 3 indexed citations

Patel, Achint, et al.. (2020). Epidemiology and Outcomes of Hospitalizations Due to Waldenstrom Macroglobulinemia: A National Perspective. Blood. 136(Supplement 1). 37–37. 2 indexed citations

Paul, Sonal, et al.. (2020). ABO Blood Type and Outcomes in a Diverse COVID-19 Infected Population. Blood. 136(Supplement 1). 27–28. 1 indexed citations

Cancarevic, Ivan, et al.. (2020). Prevalence Trend and Predictors of Clostridium Difficile Infection in Sickle Cell Disease Patients. Blood. 136(Supplement 1). 5–6.

10.

Paul, Sonal, et al.. (2020). Role of Immune Checkpoint Inhibitors in Gastrointestinal Malignancies. Journal of Clinical Medicine. 9(8). 2533–2533. 15 indexed citations

11.

Paul, Sonal, et al.. (2020). Clinical Course and Outcomes of Sickle Cell Disease Patients with COVID-19 at a New York Hospital. Blood. 136(Supplement 1). 34–36. 2 indexed citations

12.

Patel, Nisha, et al.. (2020). Evaluation of Antiplatelet and Anticoagulation Therapy in High-Risk COVID-19 Patients. Blood. 136(Supplement 1). 12–13. 1 indexed citations

13.

Fessas, Petros, Ahmed O. Kaseb, Yinghong Wang, et al.. (2020). Post-registration experience of nivolumab (nivo) therapy in patients with advanced hepatocellular carcinoma (HCC): An international study.. Journal of Clinical Oncology. 38(15_suppl). e16677–e16677. 1 indexed citations

14.

Paul, Sonal, et al.. (2019). Racial Disparities with Esophageal Cancer Mortality at a High-Volume University Affiliated Center: An All ACCESS Invitation. Journal of the National Medical Association. 112(5). 478–483. 3 indexed citations

15.

Jacob, Christopher G., et al.. (2016). The impact of disinfectant cap implementation on central line-associated bloodstream infections. Infectious Diseases. 48(8). 646–648. 1 indexed citations

16.

Manegold, C., R. Gervais, K Aigner, et al.. (2003). 57 Pemetrexed vs docetaxel: a phase III study in patients with advanced non-small cell lung cancer (NSCLC) who were previously treated with chemotherapy. European Journal of Cancer Supplements. 1(5). S22–S22. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact